RecruitingNCT04827316
Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
4,200 participants
Start Date
Jun 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adult individual >18 years
- Undergoing clinically indicated CCTA
- Signed informed consent or waiver
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04827316
Related Trials
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582901 location
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
NCT0665783313 locations
Product Surveillance Registry
NCT01524276395 locations
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT0686315512 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069016 locations